Abstract
Objective Given the high cost of endoscopy in gastric cancer (GC) screening, there is an urgent need to explore cost-effective methods for the large-scale prediction of precancerous lesions of gastric cancer (PLGC). We aim to construct a hierarchical artificial intelligence-based multimodal non-invasive method for pre-endoscopic risk screening, to provide tailored recommendations for endoscopy.
Design From December 2022 to December 2023, a large-scale screening study was conducted in Fujian, China. Based on traditional Chinese medicine theory, we simultaneously collected tongue images and inquiry information from 1034 participants, considering the potential of these data for PLGC screening. Then, we introduced inquiry information for the first time, forming a multimodality artificial intelligence model to integrate tongue images and inquiry information for pre-endoscopic screening. Moreover, we validated this approach in another independent external validation cohort, comprising 143 participants from the China-Japan Friendship Hospital.
Results A multimodality artificial intelligence-assisted pre-endoscopic screening model based on tongue images and inquiry information (AITonguequiry) was constructed, adopting a hierarchical prediction strategy, achieving tailored endoscopic recommendations. Validation analysis revealed that the area under the curve (AUC) values of AITonguequiry were 0.74 for PLGC (95% confidence interval (CI) 0.71 to 0.76, p < 0.05) and 0.82 for high-risk PLGC (95% CI 0.82 to 0.83, p < 0.05), which were significantly and robustly better than those of the independent use of either tongue images or inquiry information alone, and also demonstrated superior performance compared to existing screening methodologies. In the independent external verification, the AUC values were 0.69 for PLGC and 0.76 for high-risk PLGC.
Conclusion Our AITonguequiry artificial intelligence model, for the first time, incorporates inquiry information and tongue images, leading to a higher precision and finer-grained pre-endoscopic screening of PLGC. This enhances patient screening efficiency and alleviates patient burden.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Natural Science Foundation of China (62061160369). National Natural Science Foundation of China (Grant Nos. T2341008).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approved by the Biomedical Research Ethics Committee of Fujian Medical University ([2020] Approval No. (58) of Fujian Medical Ethics Approval), the "Fujian Province Prospective Cohort Study on Human Populations" project complies with relevant medical ethics regulations and requirements. It is agreed to be implemented according to the predetermined protocol under the premise of informed consent. Ethics Committee of Biomedical Research, Fujian Medical University 2020.04.13
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Financial Support: National Natural Science Foundation of China (62061160369). National Natural Science Foundation of China (Grant Nos. T2341008).
(3) Data availability
The data of individual deidentified participants will not be shared, but it is available upon request via email: shaoli{at}mail.tsinghua.edu.cn.
